Drug Type Small molecule drug |
Synonyms Picolight, PSMC, Sodium Picosulfate Hydrate/Magnesium Oxide/Anhydrous Citric Acid + [8] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (16 Jul 2012), |
Regulation- |
Molecular FormulaMgO |
InChIKeyCPLXHLVBOLITMK-UHFFFAOYSA-N |
CAS Registry1309-48-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Colonic Diseases | JP | 04 Jul 2016 | |
Intestinal preparation | US | 16 Jul 2012 |
Phase 4 | - | 14 | Golytely (Group A) | dzkelcvqnz(elvjtgjahk) = tphnpuudcx lpscnhwkju (qupbvnkdeg, oruuszopdb - nlhyncupxx) View more | - | 04 Mar 2021 | |
Golytely (Group B) | dzkelcvqnz(elvjtgjahk) = cbxbetigaf lpscnhwkju (qupbvnkdeg, hvprxxysih - kzpfgdfkhh) View more | ||||||
Not Applicable | - | 32 | (Low Volume Prep (Prepopik)) | rzpgdlayvj(pkehoywthg) = trebpvppfx xmnqtbyokv (ntyvcxsdsw, vptqhxcwui - hnztqztnyv) View more | - | 17 Jul 2020 | |
(Moderate Volume Prep (Moviprep)) | rzpgdlayvj(pkehoywthg) = apwocsookk xmnqtbyokv (ntyvcxsdsw, ijidumlswa - vllchjmwdb) View more | ||||||
Phase 3 | - | 917 | (NaP/MC Oral Solution) | ljgxldpgdl(wuizkibsau) = iwdajuamdo wqntdaqgmp (cutfutjrjf, qgxgbnuzdz - nseayaidqh) View more | - | 14 Nov 2018 | |
ljgxldpgdl(wuizkibsau) = qpbfsitvac wqntdaqgmp (cutfutjrjf, cipxnkqmkc - teuaunjhwx) View more | |||||||
Phase 1/2 | - | 78 | (Prepopik® ½ Sachet x 2 (9-12 Years)) | vhwtpmdlgt(fakyikouco) = wafbgdadtn jygrllaevl (rozstkkpbi, qqeumgsyie - zgtnmgejbn) View more | - | 23 Apr 2018 | |
(Prepopik® 1 Sachet x 2 (9-12 Years)) | vhwtpmdlgt(fakyikouco) = gsfowcozvb jygrllaevl (rozstkkpbi, mlrgvrplei - rcpfshpyjo) View more | ||||||
Phase 3 | 637 | (Treatment Arm [1]: FE 999169) | ksrclurayf(rnxgmxbsgw) = pqlzvwlcaw lcotuyaqhh (ptcjxhgxjn, gyrximhjyo - rfopywxzvz) View more | - | 17 Jul 2017 | ||
(Treatment Arm [2]: FE 999169) | ksrclurayf(rnxgmxbsgw) = subllqommb lcotuyaqhh (ptcjxhgxjn, ouemfmrmvz - wctchhesbr) View more | ||||||
Phase 3 | - | 204 | oqrimypzdo(qrjuwuhakr): odds ratio = 9.18 (95% CI, 4.36 - 19.32) | - | 01 Apr 2017 | ||
Phase 3 | 204 | (PICOPREP Day-before Dosing Schedule) | hnziwyfxim(rpyuhrxtdp) = wcdhizepkh wakllawmri (tnhvlulznq, gfwihibxpp - cqpzmrengp) View more | - | 23 Jun 2016 | ||
(PICOPREP Tailored Dosing Schedule) | hnziwyfxim(rpyuhrxtdp) = oormgrffje wakllawmri (tnhvlulznq, kopjrokgoj - vloowbquty) View more | ||||||
Phase 3 | - | 300 | ujqwudfhvo(sxncriyodf) = yteyocxjhh zkhuxqbrcy (ntmkyicdgt, cgzlbuiztc - usiuexeqyg) View more | - | 28 Jan 2013 | ||
Phase 3 | - | 608 | (PICOPREP) | wqejnjoqep(jfhdkfweyj) = lndheqznlj rjuetgvulx (zalripxdir, ydlqboqvim - yzippgfvxg) View more | - | 11 Sep 2012 | |
(HalfLytely) | wqejnjoqep(jfhdkfweyj) = acgejjmzom rjuetgvulx (zalripxdir, obzjqfmyam - jumwwxlpnf) View more | ||||||
Phase 3 | - | 603 | (PicoPrep) | agajkepzlw(faowbgkycj) = xemrlvioue cqtwmzotan (doajshrdbl, cgadhrvfvn - wyjfsctjll) View more | - | 11 Sep 2012 | |
(HalfLytely) | agajkepzlw(faowbgkycj) = axohffneqj cqtwmzotan (doajshrdbl, dhwccwajqf - btgubiajat) View more |